Search

This article provides the risks associated with leads of traditional defibrillators and raises awareness of the subcutaneous ICD and their benefits for hemodialysis patients” Vachharajani et al (2017).

Abstract:

Defibrillation can be successfully provided by the subcutaneous implantable cardioverter defibrillator (ICD) without the leads. In contrast, traditional ICDs require leads that can cause central venous stenosis, lead-induced endocarditis, and carry the risk of tricuspid regurgitation by valve adhesion, perforation, coaptation interference, or entanglement.

[ctt link=”scdm3″ template=”1″]ReTweet if useful… The role of subcutaneous defibrillators for dialysis patients https://ctt.ec/scdm3+ @ivteam #ivteam[/ctt]

Central venous stenosis, infection, and tricuspid regurgitation are all critically important considerations in hemodialysis patients. Recent reports are supporting the use of subcutaneous ICDs in renal patients maintained on long-term hemodialysis. This article provides the risks associated with leads of traditional defibrillators and raises awareness of the subcutaneous ICD and their benefits for hemodialysis patients.

Reference:

Vachharajani, T.J., Salman, L., Costanzo, E.J., Mehandru, S.K., Patel, M., Calderon, D.M., Mathew, R.O., Sidhu, M.S. and Asif, A. (2017) Subcutaneous defibrillators for dialysis patients. Hemodialysis International. June 23rd. [Epub ahead of print].

doi: 10.1111/hdi.12577.

Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]